Skip to main content

Thapsigargin

BML-PE180

75 citations

  • BML-PE180-0001   —   1 mg
    $89.00
  • BML-PE180-0005   —   5 mg
    $381.00
  • Potent inhibitor of SERCA
  • Cell-permeable tumor promoter

Thapsigargin is a potent inhibitor of sarco/endoplasmic reticulum Ca2+-ATPases (SERCA), which are linked with endoplasmic reticulum stress, and induces the release of intracellular stored Ca2+ without hydrolysis of inositolphospholipid (IC50=30nM). Inhibition of SERCA by thapsigargin reveals a significant change in intracellular Ca2+ homeostasis and pH regulation in tumor cells, and may be used to distinguish between discrete intracellular Ca2+ pools. Thapsigargin increases Ca2+-dependent Na+ influx in human platelets in a dose-dependent manner. Thapsigargin-induced tumor promotion and down-regulation of the EGF receptor is independent of PKC activation. Thapsigargin also stimulates nitric oxide (NO) production and as a result, may promote apoptosis.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only